Health and Wellness
The CMM platform renders real-time, continuous molecular-level insights that help inform dosing decisions.
The company says it will begin full commercial deployment of iSTRYM in the first quarter of 2022.
The company's chief product officer wrote that deleting content as quickly as possible doesn't fix the problem.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The proposed system uses brain signals and neural patterns from children.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
The Charge 5 is available today for preorder and will launch with worldwide availability in the fall.
The device predicts cardiac arrests using four primary vital signs.
The platform lets patients with rare diseases access their medical data and participate in research studies.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.